Inhibition of CB1R in the Hypothalamic Paraventricular Nucleus Ameliorates Hypertension Through Wnt/β-Catenin/RAS Pathway
Cardiovascular Toxicology · 2025
DOI: 10.1007/s12012-024-09938-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Toxicology, 2025. Verfasst von Hong-Li Gao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases, Xi'an Ji…. Hauptthemen laut MEDLINE: Paraventricular Hypothalamic Nucleus, Hypertension, Receptor, Cannabinoid, CB1, Arterial Pressure. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shaanxi Province Postdoctoral Science Foundation, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
The hypothalamic paraventricular nucleus (PVN), as an important integrating center, plays a prominent role in the pathogenesis of hypertension, in maintaining the stability of cardiovascular activity through peripheral sympathetic nervous activity and secretion of various humoral factors. Acknowledging that the mechanistic targets of the endocannabinoid type 1 receptor (CB1R) are the key signaling systems involved in the regulation of hypertension, we sought to clarify whether inhibition of CB1R within the PVN ameliorates hypertension through Wnt/β-catenin/RAS pathway. Spontaneously hypertensive rats (SHRs) and Wistar Kyoto rats were randomly assigned to different groups and treated with bilateral PVN injections of AM251 (CB1R antagonist, 10 µg/h) or vehicle (artificial cerebrospinal fluid, aCSF) for four weeks. Bilateral PVN injections of AM251 significantly decreased the heart rate, the body weight and the mean arterial pressure in SHRs. AM251 lowered the expression of CB1R, Wnt3, active-β-catenin, p-IKKβ, RAS components, pro-inflammatory cytokines and elevated the expression level of Glycogen synthase kinase3β and Superoxide Dismutase in the PVN of hypertensive rats. Our findings suggest that inhibition of CB1R in the PVN ameliorates hypertension through Wnt/β-catenin/RAS pathway and broaden our current understanding of the pathological mechanism and clinical treatment of hypertension.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases, Xi'an Jiaotong University Health Science Center, Institute of Cardiovascular S…
- Department of Physiology, Basic Medical College, Jiamusi University, Jiamusi, 154007, Heilongjiang, China.
- Department of Diagnosis, Shaanxi University of Chinese Medicine, Xi'an, 712046, China.
- Department of Pharmacology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, 710061, China.
Förderung
- National Natural Science Foundation of China
- Shaanxi Province Postdoctoral Science Foundation
- China Postdoctoral Science Foundation
- Project supported by the Open Fund for Key Laboratory of precision medicine for children's diseases in Shaanxi province
- Natural Science Basic Research Program of Shaanxi Province
Zitieren
APA
Gao, H. L., Yang, Y., Tian, H., Fu, L. Y., Liu, K. L., Jia, X. Y., Shi, X. L., Kang, Y. M., & Yu, X. J. (2025). Inhibition of CB1R in the Hypothalamic Paraventricular Nucleus Ameliorates Hypertension Through Wnt/β-Catenin/RAS Pathway. Cardiovascular Toxicology. https://doi.org/10.1007/s12012-024-09938-2
Vancouver
Gao HL, Yang Y, Tian H, Fu LY, Liu KL, Jia XY, et al. Inhibition of CB1R in the Hypothalamic Paraventricular Nucleus Ameliorates Hypertension Through Wnt/β-Catenin/RAS Pathway. Cardiovascular Toxicology. 2025. doi:10.1007/s12012-024-09938-2
BibTeX
@article{Gao2025,
author = {Gao, Hong-Li and Yang, Yu and Tian, Hua and Fu, Li-Yan and Liu, Kai-Li and Jia, Xiu-Yue and Shi, Xiao-Lian and Kang, Yu-Ming and Yu, Xiao-Jing},
title = {Inhibition of CB1R in the Hypothalamic Paraventricular Nucleus Ameliorates Hypertension Through Wnt/β-Catenin/RAS Pathway},
journal = {Cardiovascular Toxicology},
year = {2025},
doi = {10.1007/s12012-024-09938-2}
}
EUVIMED